ROXITRAC 150 Tablet

Tough Power that Delivers Results

COMPOSITION: Roxithromycin IP 150 mg



COMPOSITION: Roxithromycin IP 150 mg


Drug class: Macrolides 

  • Roxithromycin is a derivative of the macrolide antibacterial erythromycin with in vitro antibacterial activity resembling that of the parent compound.
  • As effective as more established treatments including erythromycin, amoxicillin/clavulanic acid and cefaclor.
  • In vivo, roxithromycin is as effective or more effective than other macrolides in a wide range of infections.
  • It is active against gram-positive and gram-negative cocci, gram-positive bacilli and some gram-negative bacilli, but has no significant effect on the predominant faecal flora.
  • It also displays good activity against atypical pathogens, such as Mycobacterium avium complex, Helicobacter pylori and Borrelia spp.
  • Roxithromycin significantly improved the signs and symptoms (in 3 months) of rheumatoid arthritis in adult patients and was generally well tolerated.


 Roxithromycin IP 150 mg


  1. ENT (ear, nose, throat) infections
  2. Pneumonia
  3. Skin and soft tissue infections
  4. Urogenital infections 
  5. Orodental infections 
  6. Rheumatoid arthritis